Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Andro Pharmaceuticals is a biotechnology company focused on developing innovative therapies for men's health, specifically targeting conditions related to androgen deficiency. The company's primary focus is on the development of novel small molecule modulators of the androgen receptor to treat hypogonadism and other endocrine disorders. By leveraging expertise in steroid chemistry and endocrinology, Andro Pharmaceuticals aims to provide safer and more effective alternatives to traditional testosterone replacement therapies. The company is currently advancing its lead candidates through pre-clinical validation to address significant unmet needs in the male health market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Andro Pharmaceuticals.